BCR and chronic myelogenous leukemia, BCR-ABL1 positive: More than 95% of CML patients harbor the BCR-ABL proto-oncogene 1, non-receptor tyrosine kinase (ABL1) fusion gene (BCR-ABL1), which occurs through the t(9;22)(q34;q11) chromosomal translocation [165].